Mr Alan Reid
- Principal Clinical Scientist within the Biochemistry Department, Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde.
- Scheme Organiser of UK NEQAS Cardiac Marker Service
- Executive Board Divisional Representative for Chemistry Division Currently
- Treasurer of UK NEQAS
- Research interests in the use of cardiac biomarkers in acute coronary syndrome and heart failure. From 1997 became interested in the development of cardiac marker EQA.
- Continuing to develop EQA schemes for both laboratory and point of care systems with current and future cardiac biomarkers.
- Developing current interpretative exercises to assist in clinical interpretation of cardiac biomarker testing
- Was Specialist Committee Member of NICE Guidance(DG15): Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays)
- High-sensitivity cardiac troponin and the under diagnosis of myocardial infarction in woman: a prospective cohort study. BMJ 2015; 350 doi:http://dx.doi.org/10.1136/mbj.g7873
- High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015; 386 DOI: http://dx.doi.org/10.1016/S0140-6736(15)00391-8
OTHER PROFESSIONAL ROLES INCLUDE
- Organiser of the Cardiac Marker Dialogues, an international meeting on cardiac biomarkers.
- Member of the Association of Clinical Biochemistry and the American Association of Clinical Chemistry.
- Member of HighSTEACS study group looking at high sensitivity Troponin I in the evaluation of patients with Acute Coronary Syndrome in 10 hospitals in NHS Lothian and NHS Greater Glasgow and Clyde.
- Currently a member of a group developing a candidate liquid chromatography mass spectrometry reference method for the quantification of the cardiac marker 1-32 B-type Natriuretic Peptide